Status:
COMPLETED
Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Lead Sponsor:
Actelion
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
The present trial investigates the long-term safety, tolerability and efficacy of bosentan in patients with inoperable CTEPH.
Eligibility Criteria
Inclusion
- Patients having completed the 16-week treatment period of protocol AC-052-366 (NCT00313222)
- Signed informed consent
Exclusion
- Any major violation of protocol AC-052-366 (NCT00313222)
- Pregnancy or breast-feeding
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
151 Patients enrolled
Trial Details
Trial ID
NCT00319111
Start Date
January 1 2006
End Date
April 1 2009
Last Update
February 4 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.